LITT Combined With Early Use of Temozolomide for Recurrent Glioblastomas
Status:
Active, not recruiting
Trial end date:
2024-12-30
Target enrollment:
Participant gender:
Summary
This study aims to investigate the safety and efficacy of Laser Interstitial Thermal Therapy
(LITT) combined with postoperative early use of temozolomide in treating recurrent
glioblastomas.